Eugene Viscusi, MD
Associate Professor
Director, Acute Pain Management Service
Department of Anesthesiology
Thomas Jefferson University
Philadelphia, Pennsylvania
Associate Professor
Director, Acute Pain Management Service
Department of Anesthesiology
Thomas Jefferson University
Philadelphia, Pennsylvania
Related Videos
What is the importance of opioid avoidance as a foundational strategy for multimodal pain management in the perioperative setting? And where does IV acetaminophen fit into that best pain management practice equation?
What do we know about patient satisfaction as it relates to perioperative pain management, including in patients on IV acetaminophen? And what role does opioid reduction play?
How rapid is the onset of action for IV acetaminophen and when is the C-Max achieved after a 15-minute infusion? How does the IV formulation C-Max metrics compare to the oral formulation?
What is your strategy in a patient who has become intolerant of an opioid?
What is your strategy in a patient who has become intolerant of an opioid?
What other agents or perioperative physiological factors can affect absorption of oral acetaminophen, thereby making this route potentially problematic and less reliable than IV acetaminophen?
What are the contraindications to the use of IV acetaminophen?
What are the contraindications to the use of IV acetaminophen?
What makes the side effect profile of IV acetaminophen uniquely suited for perioperative pain management as compared to IV opioids?
Is there a risk of acetaminophen masking a surgical infection because of its anti-pyretic effect?
Is there a risk of acetaminophen masking a surgical infection because of its anti-pyretic effect?
What trial-based evidence do you think is most compelling to support the use of IV acetaminophen in the setting of TKR and THR — a high pain model in orthopedic surgery context? Can you summarize the data? What did we learn about the degree ...